Advanced Biomed Inc. Common Stock (ADVB) vs MetaVia Inc. (MTVA)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and MetaVia Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.66HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
MTVA
MetaVia Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — ADVB vs MTVA
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)MTVA -91.1% (-70.1%/yr)MTVA compounded faster over this window
ADVB MTVA
ADVB vs MTVA: by the numbers
- •MTVA is the larger company ($10M vs $9M market cap).
Metrics side by side
Valuation
| Metric | ADVB | MTVA |
|---|---|---|
| P/B ratio | 1.00 | 1.42 |
Profitability
| Metric | ADVB | MTVA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -211.76% |
| ROIC | -11.06% | -215.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.